Martina P. Maurelli
Verona, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 110 publications
Dermatologic manifestations in an adult with Williams syndrome.
Journal: JAAD case reports
Published: June 08, 2026
Bullous pemphigoid developing 25 years after pemphigus vulgaris: a rare case of possible epitope spreading.
Journal: Italian journal of dermatology and venereology
Published: May 28, 2026
Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study.
Journal: The British journal of dermatology
Published: May 16, 2026
Biosimilars for chronic plaque psoriasis: a 2026 update.
Journal: Expert review of clinical pharmacology
Published: April 29, 2026
Reduced sensitization over time to parabens 16% mix in North-eastern Italy, 1997-2023.
Journal: The British journal of dermatology
Published: April 23, 2026
Real-Life Effectiveness and Safety of Lebrikizumab in Elderly Patients with Atopic Dermatitis: A Multicenter Study.
Journal: Clinical and experimental dermatology
Published: April 12, 2026
Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis).
Journal: Dermatology and therapy
Published: March 17, 2026
Real-World Long-Term Effectiveness and Safety of Secukinumab in Psoriasis: Up to 7 Years of Evidence from the Italian Landscape Psoriasis (IL PSO) Multicenter Retrospective Study.
Journal: Dermatology and therapy
Published: March 04, 2026
The mystery of the Girl with a Pearl Earring.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: January 12, 2026
Real-World Efficacy of IL-23 Inhibitors in Psoriasis Affecting High-Impact Areas: Indirect Comparison of Tildrakizumab 200 mg, Risankizumab, and Guselkumab-IL PSO (Italian Landscape Psoriasis).
Journal: Dermatology and therapy
Published: December 01, 2025
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis).
Journal: Acta dermato-venereologica
Published: November 16, 2025
Letter: Optimizing Dupilumab Dosing in Atopic Dermatitis: Real-World Evidence.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: November 07, 2025
Last Updated: 09/26/2026